Lisa Gora

Health care providers and businesses turn to attorney Lisa Gora for advice on regulatory compliance and representation in corporate transactions. Lisa is also a leader in Epstein Becker Green's psychedelic and cannabis practices, providing legal guidance to these highly regulated businesses in the evolving legal framework.

Lisa regularly analyzes federal and state statutes and regulations in connection with the federal Anti-Kickback Statute and Stark Law, New Jersey’s Codey Law and other state-specific self-referral laws, the federal False Claims Act, the New Jersey False Claims Act, Board of Medical Examiners regulations, licensing and reimbursement issues, and other fraud and abuse laws. Her clients include health care professionals as well as group practices and other health care entities, such as hospitals, academic medical centers, ambulatory surgery centers, management service organizations, ambulatory care facilities, substance use treatment facilities, mental health facilities (outpatient and inpatient), and nursing homes, among others.

Read more

Lisa’s health care, psychedelic, and cannabis clients rely on Lisa for regulatory advice and to guide them through transactional matters concerning mergers and acquisitions as well as the formation and structure of such entities, including joint ventures, affiliation agreements, and management services arrangements. Further, Lisa frequently lectures on ownership in health care practices and cannabis entities (buying in and separating from) and the related considerations and challenges.

On the forefront of the burgeoning cannabis industry and with many years of industry experience, Lisa helps clients in the cannabis space navigate the industry’s complicated and ever-changing regulatory landscape. Her cannabis law practice includes the representation of alternative treatment centers within the medicinal cannabis industry as well as start-ups and multistate operators in the personal adult-use cannabis industry, such as cultivators, manufacturers, retailers, delivery services, distributors, and testing laboratories. Lisa advises clients in connection with licensing, ownership, and regulatory compliance pursuant to state laws, rules, and regulations. Lisa also advises clients on regulatory considerations associated with anticipated mergers and acquisitions. Additionally, she provides advice to physicians, hospitals, and others doing business in the legal cannabis market in New Jersey concerning issues related to recommending, authorizing, administering, and possessing medical cannabis.

Researchers, academic medical centers, teaching hospitals, pharmaceutical manufacturers, investors, clinicians, and other stakeholders interested in psychedelic substances trust Lisa to guide them through the legal and regulatory complexities of the emerging psychedelics field.

Lisa serves as the co-chair of the psychedelic subcommittee of the New Jersey State Bar Association. She is the past Chair of the Health Law Section and the past co-chair of the Cannabis Law Committee of the New Jersey State Bar Association.

Lisa is frequently featured on Epstein Becker Green’s health law podcast, Diagnosing Health Care, discussing developments in psychedelics and cannabis across the United States, and she tracks the shifting regulatory landscape on psychedelics across the United States. She was Editor-in-Chief of the first edition of Health Care and the Business of Cannabis: Legal Questions and Answers, a first-of-its-kind project published by the American Health Law Association, which offers insight into the interplay between medicinal cannabis and the health care industry, as well as related information on legal and practical considerations in connection with business opportunities surrounding medicinal cannabis and its by-products. She also co-authored “Medical Marijuana: State and Federal Law Thickets and Practical Implications” in the Health Law Handbook, published by Thomson Reuters in May 2020. Before joining Epstein Becker Green, Lisa was Co-Chair of the Cannabis Law team and a shareholder in the Corporate and Health Law teams at a regional law firm.

Read less

Listed in:

• The Best Lawyers in America^©: Health Care Law (2024 to 2025). This award is conferred by Best Lawyers. A description of the selection methodology is available here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.
• The Best Lawyers in America^©: “One to Watch” for Corporate Law and Health Care Law (2022 to 2023) and for Corporate Law (2021). This award is conferred by Best Lawyers. A description of the selection methodology is available here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.
• Chambers USA: The World’s Leading Lawyers for Business: New Jersey—Healthcare, “Up and Coming” (2019 to 2024). This award is conferred by Chambers and Partners. A description of the selection methodology is available here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.
• The Legal 500 United States: M&A Middle Market (Sub $500 Million) (2024). This award is conferred by The Legal 500. A description of the selection methodology is available here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.
• New Jersey Law Journal: New Leader of the Bar (2020). This award is conferred by the New Jersey Law Journal. A description of the selection methodology is available here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.
• New Jersey Rising Stars: Health Care, Business/Corporate, Cannabis Law (2018 to 2024). This award is conferred by Thomson Reuters. A description of the selection methodology is available here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.
• NJ Biz: “Forty Under 40” (2024). This award is conferred by NJ Biz. A description of the selection methodology is available here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Education

• New York Law School (J.D., 2012)
• Rutgers University (B.A., cum laude, 2007)
  • Phi Beta Kappa

Professional & Community Involvement

• American Health Lawyers Association
  • Medical Staff, Credentialing, and Peer Review Practice Group, Chair (2019 to Present), Vice Chair (2016 to 2019)
• Law360 Cannabis Editorial Board (2022, 2023)
• New Jersey State Bar Association
  • Cannabis Law Section, Chair (2021 to Present)
  • Health Law Section, Chair (2021 to Present), Vice Chair (2019 to 2020), Secretary (2018 to 2019)

Upcoming Events

Past Events